PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Actinogen Medical Limited (ACW.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU000000ACW3

Sector

Healthcare

IPO Date

Oct 15, 2007

Highlights

Market Cap

A$78.32M

EPS (TTM)

-A$0.01

Total Revenue (TTM)

A$9.02M

Gross Profit (TTM)

A$9.02M

EBITDA (TTM)

-A$1.44M

Year Range

A$0.02 - A$0.10

Target Price

A$0.15

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Actinogen Medical Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-66.23%
12.26%
ACW.AX (Actinogen Medical Limited)
Benchmark (^GSPC)

Returns By Period

Actinogen Medical Limited had a return of 4.00% year-to-date (YTD) and 13.04% in the last 12 months. Over the past 10 years, Actinogen Medical Limited had an annualized return of -7.88%, while the S&P 500 had an annualized return of 11.23%, indicating that Actinogen Medical Limited did not perform as well as the benchmark.


ACW.AX

YTD

4.00%

1M

-7.14%

6M

-66.23%

1Y

13.04%

5Y*

-5.64%

10Y*

-7.88%

^GSPC (Benchmark)

YTD

-0.77%

1M

-3.55%

6M

3.64%

1Y

22.00%

5Y*

12.20%

10Y*

11.23%

*Annualized

Monthly Returns

The table below presents the monthly returns of ACW.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202431.82%13.79%-3.03%17.19%-22.67%113.79%14.52%-36.62%-46.67%-0.00%12.50%-7.41%13.64%
2023-10.09%-7.75%-18.07%-5.82%-28.13%-13.12%-7.55%-29.58%-20.00%-15.00%41.18%-8.33%-77.11%
2022-24.98%-21.68%11.74%-15.26%-21.40%-28.57%20.00%30.03%14.15%46.08%-15.37%-9.08%-37.48%
2021-4.95%5.21%85.64%69.07%74.29%13.03%-19.22%4.76%13.62%15.99%-10.34%23.06%660.89%
2020-2.95%-31.31%-16.81%5.32%-9.60%15.64%4.35%13.43%3.67%-20.47%4.46%-4.27%-40.41%
201919.81%3.74%-3.61%-3.74%-76.89%-16.81%-9.57%-11.76%13.33%265.88%36.33%-20.05%-20.05%
2018-2.33%27.32%-7.92%-8.37%13.83%-1.95%22.79%-3.24%-10.61%-5.83%-8.41%2.42%9.84%
2017-20.80%3.35%6.85%42.83%-22.20%-12.90%-3.31%-25.41%27.29%-5.31%-15.03%-8.96%-43.07%
2016-16.38%11.88%27.93%16.45%7.12%-20.89%-0.00%-26.40%-15.03%-15.57%28.77%47.07%18.12%
201528.77%15.57%23.77%20.49%-20.94%-8.87%-16.67%-13.45%15.54%-1.77%-15.14%21.87%35.38%
2014-0.00%13.53%80.43%-33.49%-29.79%-47.47%62.50%161.54%-14.71%9.81%0.00%2.42%104.83%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ACW.AX is 57, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ACW.AX is 5757
Overall Rank
The Sharpe Ratio Rank of ACW.AX is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of ACW.AX is 7070
Sortino Ratio Rank
The Omega Ratio Rank of ACW.AX is 7171
Omega Ratio Rank
The Calmar Ratio Rank of ACW.AX is 4949
Calmar Ratio Rank
The Martin Ratio Rank of ACW.AX is 4949
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Actinogen Medical Limited (ACW.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for ACW.AX, currently valued at 0.00, compared to the broader market-2.000.002.000.001.73
The chart of Sortino ratio for ACW.AX, currently valued at 1.27, compared to the broader market-4.00-2.000.002.004.001.272.33
The chart of Omega ratio for ACW.AX, currently valued at 1.18, compared to the broader market0.501.001.502.001.181.32
The chart of Calmar ratio for ACW.AX, currently valued at 0.00, compared to the broader market0.002.004.006.000.002.59
The chart of Martin ratio for ACW.AX, currently valued at 0.00, compared to the broader market0.0010.0020.000.0010.80
ACW.AX
^GSPC

The current Actinogen Medical Limited Sharpe ratio is 0.00. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Actinogen Medical Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
0.00
2.66
ACW.AX (Actinogen Medical Limited)
Benchmark (^GSPC)

Dividends

Dividend History


Actinogen Medical Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-96.10%
-2.67%
ACW.AX (Actinogen Medical Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Actinogen Medical Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Actinogen Medical Limited was 99.01%, occurring on Sep 11, 2019. The portfolio has not yet recovered.

The current Actinogen Medical Limited drawdown is 96.10%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.01%Oct 17, 20073009Sep 11, 2019

Volatility

Volatility Chart

The current Actinogen Medical Limited volatility is 21.72%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%AugustSeptemberOctoberNovemberDecember2025
21.72%
3.34%
ACW.AX (Actinogen Medical Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Actinogen Medical Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Actinogen Medical Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab